FDA OKs Pfizer COVID-19 Vaccine For 12-15 Age Group
Pfizer said in late March that clinical trials found "100% efficacy and robust antibody responses" to the coronavirus in 12- to 15-year-olds.
Read more on NPR
Pfizer said in late March that clinical trials found "100% efficacy and robust antibody responses" to the coronavirus in 12- to 15-year-olds.
Read more on NPR
This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.
ConversionConversion EmoticonEmoticon